RecruitingNot ApplicableNCT07285031

Histamines and Central Hemodynamics

The Role of Histamines on Central Hemodynamics


Sponsor

University of British Columbia

Enrollment

20 participants

Start Date

Dec 1, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

When we exercise, more blood flow goes to our muscles, challenging our blood vessels. Following exercise, blood flow remains elevated and seems to be the reason for many of the positive cardiovascular benefits that occur with exercise. When the actions of histamine, a molecule primarily known for its role in allergies, are blocked, there is an attenuated blood flow response following exercise. However, this effect has never been studied in the blood vessels that supply our lungs. The purpose of this study is to examine the effects of histamines on pulmonary hemodynamics following exercise.


Eligibility

Min Age: 19 YearsMax Age: 39 Years

Inclusion Criteria2

  • Age: 19 - 39.
  • Willing to visit the lab on 3 separate occasions.

Exclusion Criteria13

  • Previously diagnosed heart condition,
  • Previously diagnosed lung condition (including asthma),
  • Previously diagnosed metabolic condition,
  • Currently smokers (cigarettes, electronic cigarettes, cannabis) or who have smoked within the last 3 months,
  • Resting blood pressure \>140/90 mmHg,
  • Unable to obtain appropriate quality ultrasound images of the heart.,
  • Individuals without tricuspid regurgitation at rest to allow assessment of the primary outcome,
  • Pregnant or trying to become pregnant,
  • Breastfeeding,
  • Chronically take antihistamines (i.e. daily),
  • History of adverse reactions to antihistamines,
  • Never taken antihistamines previously,
  • Currently taking any medications (including oral contraceptives).

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGDiphenhydramine hydrochloride

H1 receptor antagonist: 50mg Diphenhydramine Hydrochloride

OTHERPlacebo

Placebo

OTHERExercise Bout

Participants will complete a total of three 5-minute high intensity exercise intervals, interspersed with 5-minute lower intensity exercise bouts (4 total), for a total of 35 minutes.


Locations(1)

University of British Columbia

Kelowna, British Columbia, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07285031


Related Trials